Also, CCC does not show the polyphenotypic immunohistochemical expression typical of SSCOHT, but is, instead, positive for Napsin A. Among non-ovarian solid tumors, inactivating mutations of SMARCA4 have been rarely described in lung adenocarcinomas, and were associated with a poor outcome (2). Here, SMARCA4 is linked to lung adenocarcinoma.